Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home button

Trial Design: Pain Sections
Author Bio
Introduction
Placebo Effects
Single Dose Trials
Repeated Dose Trials
Explanatory Versus Pragmatic
Currently selected section: Dose-Response
Parallel Group Versus Crossover
Conclusion
 

 

Chapter 1: Clinical Trials of Pain Treatment: Dose-Response; Relative Potency; Combinations

 
         

If such a conversion is studied in only one direction, the tendency of pain to worsen with cancer progression will tend to increase the required dose and decrease the potency estimate of the second drug.

You answered:

True Worsening of painful lesions from progressive cancer may cause a dose overestimate.

CORRECT

Worsening of painful lesions from progressive cancer may cause an overestimate of the dose of fentanyl needed to replace morphine if one tries to extrapolate the estimate to a different clinical situation, e.g. one is changing drugs in the opposite direction, or if one is treating a nonprogressive pain condition.

 

      Back to Question